AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33585991 — intervention group
Group type: COMPARATOR
Intervention: Stent placement only (Control)
Number of subjects: 135
Study 33585991 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events related to biliary tract operation
Number of subjects: 135
Study 36221346 — intervention group
Group type: EXPERIMENTAL
Intervention: T2 (T = 36 ± 1°C)
Number of subjects: 144
Study 36221346 — intervention group
Group type: EXPERIMENTAL
Intervention: T3 (T = 40 ± 1°C)
Number of subjects: 144
Study 36221346 — intervention group
Group type: EXPERIMENTAL
Intervention: T4 (T = 48 ± 1°C)
Number of subjects: 144
Study 36221346 — intervention group
Group type: COMPARATOR
Intervention: T1 (T = 24 ± 1°C)
Number of subjects: 144
Study 33704030 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-range reindeer (FR)
Number of subjects: 7
Study 33704030 — intervention group
Group type: COMPARATOR
Intervention: Commercial beef (CB)
Number of subjects: 7
Study 32041671 — intervention group
Group type: EXPERIMENTAL
Intervention: Edible ectomycorrhizal fungi from the Yangambi Biosphere reserve and Yoko forest reserve
Number of subjects: 160
Study 32041671 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed forest stands
Number of subjects: 160
Study 32041671 — intervention group
Group type: COMPARATOR
Intervention: Monodominant forests
Number of subjects: 160
Study 34240455 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-071 40-80 mg
Number of subjects: 0
Study 34240455 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-071 120-160 mg
Number of subjects: 0
Study 34240455 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-071 (high doses)
Number of subjects: 0
Study 34240455 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-071 with donepezil
Number of subjects: 0
Study 34240455 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-071 (overall)
Number of subjects: 0
Study 33017484 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 1
Study 33017484 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily plasma exchange and oral prednisone
Number of subjects: 1
Study 34794178 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 vaccination among REPRIEVE participants
Number of subjects: 6952
Study 34794178 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with COVID-19 vaccination
Number of subjects: 6952
Study 32937046 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy
Number of subjects: 243
Study 32937046 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ambient air from a sham concentrator)
Number of subjects: 243
Study 36300280 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐rhG‐CSF
Number of subjects: 40
Study 36300280 — intervention group
Group type: COMPARATOR
Intervention: rhG‐CSF
Number of subjects: 40
Study 33905134 — intervention group
Group type: EXPERIMENTAL
Intervention: EVE (leuprorelin + LET + EVE)
Number of subjects: 137
Study 33905134 — intervention group
Group type: COMPARATOR
Intervention: LET (leuprorelin + LET)
Number of subjects: 137
Study 33905134 — intervention group
Group type: EXPERIMENTAL
Intervention: EVE + LET with ovarian suppression
Number of subjects: 137
Study 32990214 — intervention group
Group type: EXPERIMENTAL
Intervention: HUG116 tablet; tenofovir disoproxil
Number of subjects: 50
Study 32990214 — intervention group
Group type: COMPARATOR
Intervention: Viread tablet; tenofovir disoproxil fumarate
Number of subjects: 50
Study 35357396 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotuximab plus pazopanib
Number of subjects: 123
Study 35357396 — intervention group
Group type: COMPARATOR
Intervention: Pazopanib alone
Number of subjects: 123
Study 36057498 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming (38°C)
Number of subjects: 120
Study 36057498 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed intravenous fluid (37°C)
Number of subjects: 120
Study 36057498 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 32762590 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity HVC communication skills curriculum
Number of subjects: 30
Study 32762590 — intervention group
Group type: COMPARATOR
Intervention: Standard HVC communication SP encounter
Number of subjects: 30
Study 36164121 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirtobrutinib monotherapy
Number of subjects: 500
Study 36164121 — intervention group
Group type: COMPARATOR
Intervention: Investigator's choice of covalent BTK inhibitor monotherapy (ibrutinib, acalabrutinib, or zanubrutinib)
Number of subjects: 500
Study 33999521 — intervention group
Group type: EXPERIMENTAL
Intervention: Semen swim-up
Number of subjects: 60
Study 33999521 — intervention group
Group type: EXPERIMENTAL
Intervention: Pellet swim-up
Number of subjects: 60
Study 33999521 — intervention group
Group type: EXPERIMENTAL
Intervention: Density gradient
Number of subjects: 60
Study 33999521 — intervention group
Group type: EXPERIMENTAL
Intervention: Density gradient followed by semen swim-up
Number of subjects: 60
Study 32628620 — intervention group
Group type: EXPERIMENTAL
Intervention: Subvastus (S) exposure
Number of subjects: 60
Study 32628620 — intervention group
Group type: COMPARATOR
Intervention: Medial parapatellar (MP) exposure
Number of subjects: 60
Study 35670067 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 5988
Study 35670067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988
Study 35334973 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel fermented miso-type sauce enhanced with 50% carotenoid-rich fruit peel extract
Number of subjects: 14
Study 35334973 — intervention group
Group type: COMPARATOR
Intervention: Rice meal with legume-based sauce (control)
Number of subjects: 14
Study 32028253 — intervention group
Group type: COMPARATOR
Intervention: Brief Advice (BA)
Number of subjects: 395
Study 32028253 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 395
Study 32028253 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI + B (with telephone booster)
Number of subjects: 395
Study 37755683 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program including supervised walking, squat, balance, and inspiratory muscle training (IMT) with two daily sessions.
Number of subjects: 174
Study 37755683 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with no specific intervention mentioned.
Number of subjects: 174
Study 37755683 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program including IMT.
Number of subjects: 174
Study 34529735 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual feedback letters reporting measured physical activity (PA) and physical inactivity (PI)
Number of subjects: 166
Study 34529735 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback letters)
Number of subjects: 166
Study 34529735 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 166
Study 34529735 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study 32898690 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram developed from clinical data using univariate and multivariate Cox regression analyses.
Number of subjects: 98640
Study 36157826 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP)
Number of subjects: 102
Study 32331476 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal intake after resistance exercise (Post)
Number of subjects: 8
Study 32331476 — intervention group
Group type: COMPARATOR
Intervention: Meal intake before resistance exercise (Pre)
Number of subjects: 8
Study 32331476 — intervention group
Group type: COMPARATOR
Intervention: RE without meal intake (No)
Number of subjects: 8
Study 35083807 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive physical fitness age information
Number of subjects: 253
Study 35083807 — intervention group
Group type: COMPARATOR
Intervention: Control group (no predictive physical fitness age information)
Number of subjects: 253
Study 32053067 — intervention group
Group type: EXPERIMENTAL
Intervention: Various pharmaceutical agents (gonadotropins, anti‐estrogen agents, aromatase inhibitors)
Number of subjects: 0
Study 32053067 — intervention group
Group type: COMPARATOR
Intervention: Placebo (implied control)
Number of subjects: 0
Study 35113160 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan (T-DXd)
Number of subjects: 1452
Study 35113160 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathologist assessment of breast cancer biopsies
Number of subjects: 1452
Study 32919045 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 1 hour prior to the procedure and for 3 weeks postoperatively
Number of subjects: 157
Study 32919045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 34265312 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (1 mg/kg po QID)
Number of subjects: 40
Study 33297843 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal 1 mA tDCS
Number of subjects: 52
Study 33297843 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 52
Study 32593228 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning on smartphones with interactive learning materials including videos of dental treatments
Number of subjects: 293
Study 32593228 — intervention group
Group type: COMPARATOR
Intervention: Control group with no learning materials
Number of subjects: 293
Study 33908131 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol administration in humans
Number of subjects: 0
Study 33908131 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol administration in Ghsr knockout and wild-type rats
Number of subjects: 0
Study 33908131 — intervention group
Group type: COMPARATOR
Intervention: Alcohol administration versus calorically equivalent non-alcoholic sucrose solution in rats
Number of subjects: 0
Study 33908131 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol administration on ghrelin secretion from gastric mucosa cells ex vivo
Number of subjects: 0
Study 33908131 — intervention group
Group type: EXPERIMENTAL
Intervention: GOAT enzymatic activity in vitro
Number of subjects: 0
Study 34490583 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol
Number of subjects: 0
Study 34490583 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable MR analysis
Number of subjects: 0
Study 34490583 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse MR analysis
Number of subjects: 0
Study 35932720 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine (10 UI once a day for 7 days)
Number of subjects: 36
Study 35932720 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (control group, once a day for 7 days)
Number of subjects: 36
Study 33011095 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise-training program (2 sessions/day for 5 to 7 consecutive days)
Number of subjects: 185
Study 33011095 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise-training program
Number of subjects: 185
Study 33011095 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group (habitual hospital care)
Number of subjects: 185
Study 34625211 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG) implemented by teachers in intervention schools during the 2-year main trial period (Time 1 to Time 3)
Number of subjects: 3084
Study 34625211 — intervention group
Group type: COMPARATOR
Intervention: Usual practice by teachers in control schools
Number of subjects: 3084
Study 35543543 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% CHX
Number of subjects: 61
Study 35543543 — intervention group
Group type: COMPARATOR
Intervention: 4% CHX
Number of subjects: 61
Study 33044837 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based nursing education
Number of subjects: 128
Study 35306386 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 27
Study 35306386 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and NMES (EX + NMES)
Number of subjects: 27
Study 35306386 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 27
Study 35306386 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional capacity
Number of subjects: 27
Study 35306386 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness
Number of subjects: 27
Study 35306386 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 27
Study 35306386 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung function
Number of subjects: 27
Study 33843296 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (examination and advice by a rheumatologist and a physiotherapist)
Number of subjects: 476
Study 33843296 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary intervention (brief intervention plus coaching by a case manager)
Number of subjects: 476
Study 33843296 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 476
Study 33843296 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary intervention
Number of subjects: 476
Study 33218847 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 580
Study 33218847 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 580
Study 33218847 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher self-efficacy
Number of subjects: 580
Study 33218847 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthier eating intentions
Number of subjects: 580
Study 33218847 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthier household food patterns
Number of subjects: 580
Study 32643076 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics
Number of subjects: 5
Study 32643076 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics/placebo
Number of subjects: 5
Study 35211743 — intervention group
Group type: EXPERIMENTAL
Intervention: Roluperidone 64 mg/day
Number of subjects: 513
Study 35211743 — intervention group
Group type: COMPARATOR
Intervention: Roluperidone 32 mg/day
Number of subjects: 513
Study 35211743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study 35662406 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg bodyweight orally three times per week)
Number of subjects: 130
Study 35662406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 35385369 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD-CPHS screening questionnaire (cutoff point ≥16)
Number of subjects: 33664
Study 35385369 — intervention group
Group type: EXPERIMENTAL
Intervention: Development set AUC
Number of subjects: 33664
Study 35385369 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation set AUC
Number of subjects: 33664
Study 33270298 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-PV trigger-targeted ablation (Group 2)
Number of subjects: 300
Study 33270298 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-PV trigger-targeted ablation (Group 1)
Number of subjects: 300
Study 33270298 — intervention group
Group type: COMPARATOR
Intervention: Non-PV triggers still inducible after CA (Group 3)
Number of subjects: 300
Study 32631129 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine
Number of subjects: 0
Study 34697034 — intervention group
Group type: EXPERIMENTAL
Intervention: A. soehngenii infusion
Number of subjects: 12
Study 34697034 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12
Study 33138708 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 390
Study 33138708 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 390
Study 33138708 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 390
Study 33138708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study 33138708 — intervention group
Group type: COMPARATOR
Intervention: Control group (without psychiatric illness)
Number of subjects: 390
Study 37656449 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic ranibizumab (PR) injections every 3 months
Number of subjects: 0
Study 37656449 — intervention group
Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 0
Study 33754371 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 54
Study 33754371 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 54
Study 32306247 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec 200 units/mL
Number of subjects: 0
Study 32306247 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 300 units/mL
Number of subjects: 0
Study 36074760 — intervention group
Group type: EXPERIMENTAL
Intervention: Tighter glycaemic targets (FPG ≤5.0 mmol/L, 1-hour ≤7.4 mmol/L, 2-hour postprandial ≤6.7 mmol/L)
Number of subjects: 1100
Study 36074760 — intervention group
Group type: EXPERIMENTAL
Intervention: Tighter glycaemic targets
Number of subjects: 1100
Study 36074760 — intervention group
Group type: COMPARATOR
Intervention: Less tight glycaemic targets (FPG <5.5 mmol/L, 1-hour <8.0 mmol/L, 2-hour postprandial <7.0 mmol/L)
Number of subjects: 1100
Study 36074760 — intervention group
Group type: COMPARATOR
Intervention: Less tight glycaemic targets
Number of subjects: 1100
Study 32699911 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed muffins (30 g total, consumed once in the morning)
Number of subjects: 15
Study 32699911 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed muffins (10 g per muffin, consumed three times a day)
Number of subjects: 15
Study 32699911 — intervention group
Group type: COMPARATOR
Intervention: Control muffins (0 g flaxseed, consumed three times a day)
Number of subjects: 15
Study 35193378 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe
Number of subjects: 20
Study 35193378 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 20
Study 33308907 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily disposable toric contact lenses
Number of subjects: 38
Study 35664958 — intervention group
Group type: EXPERIMENTAL
Intervention: Khorasan wheat diet
Number of subjects: 20
Study 35664958 — intervention group
Group type: COMPARATOR
Intervention: Control wheat diet
Number of subjects: 20
Study 33961006 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (0.5-1.0 mg daily)
Number of subjects: 11600
Study 32594766 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C target of <70 mg/dL
Number of subjects: 413
Study 32594766 — intervention group
Group type: COMPARATOR
Intervention: LDL-C target of 100±10 mg/dL
Number of subjects: 413
Study 33148134 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 45
Study 33148134 — intervention group
Group type: COMPARATOR
Intervention: Mobilization
Number of subjects: 45
Study 32423275 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine HFA (Primatene® MIST)
Number of subjects: 23
Study 32423275 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine CFC (Primatene® MIST CFC)
Number of subjects: 23
Study 36060654 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboprost aminobutyriol combined with oxytocin
Number of subjects: 120
Study 36060654 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 120
Study 33774942 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ozonated sunflower oil (950 peroxide value) applied daily for one week
Number of subjects: 36
Study 33774942 — intervention group
Group type: COMPARATOR
Intervention: Non-ozonated sunflower oil (control) applied daily for one week
Number of subjects: 36
Study 33774942 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ozonated sunflower oil
Number of subjects: 36
Study 34772441 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotic treatment after 2 weeks of IV antibiotic therapy
Number of subjects: 450
Study 34772441 — intervention group
Group type: COMPARATOR
Intervention: Standard 6-8 weeks of IV antibiotics
Number of subjects: 450
Study 34772441 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotic treatment
Number of subjects: 450
Study 34772441 — intervention group
Group type: COMPARATOR
Intervention: Standard IV antibiotics
Number of subjects: 450
Study 32466190 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels classified as light, moderate, vigorous
Number of subjects: 6875
Study 32466190 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Body Mass Index (BMI)
Number of subjects: 6875
Study 32466190 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 6875
Study 35079029 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin (INI)
Number of subjects: 0
Study 35079029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35079029 — intervention group
Group type: COMPARATOR
Intervention: Intranasal insulin (INI) and Placebo
Number of subjects: 0
Study 32737613 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% fat milk
Number of subjects: 44
Study 32737613 — intervention group
Group type: COMPARATOR
Intervention: apple juice
Number of subjects: 44
Study 32737613 — intervention group
Group type: COMPARATOR
Intervention: water
Number of subjects: 44
Study 34416060 — intervention group
Group type: EXPERIMENTAL
Intervention: FPE-D (fermented pomegranate extract drink)
Number of subjects: 80
Study 34416060 — intervention group
Group type: EXPERIMENTAL
Intervention: FPE-S (fermented pomegranate extract serum)
Number of subjects: 80
Study 34416060 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 80
Study 34416060 — intervention group
Group type: COMPARATOR
Intervention: Placebo serum
Number of subjects: 80
Study 34509600 — intervention group
Group type: EXPERIMENTAL
Intervention: l-glutamine
Number of subjects: 0
Study 34509600 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 35600633 — intervention group
Group type: EXPERIMENTAL
Intervention: AYUSH 64 (3 gm per day in three divided doses for 14 days)
Number of subjects: 80
Study 35600633 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC) alone
Number of subjects: 80
Study 33471548 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal boost arm (95 Gy, fractions up to 2.7 Gy)
Number of subjects: 571
Study 33471548 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment arm (77 Gy, fractions of 2.2 Gy)
Number of subjects: 571